Establishment of a Quantitative Polymerase Chain Reaction Assay for Monitoring Chimeric Antigen Receptor T Cells in Peripheral Blood.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Transplantation Proceedings

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.transproceed.2017.11.028PMID 29407291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correction: MeltMan: Optimization, Evaluation, and Universal Application of a qPCR System Integrating the TaqMan qPCR and Melting Analysis into a Single Assay

  2016cited by this paper
• Chimeric Antigen Receptor (CAR) therapy for multiple myeloma

  2016cited by this paper
• Driving gene-engineered T cell immunotherapy of cancer

  2016cited by this paper
• CAR T Cell Therapy: A Game Changer in Cancer Treatment

  2016cited by this paper
• Chimeric antigen receptor T cells targeting Fc μ receptor selectively eliminate CLL cells while sparing healthy B cells.

  2016cited by this paper
• Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cells

  2016cited by this paper
• CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date.

  2016cited by this paper
• Dynamic imaging for CAR-T-cell therapy.

  2016cited by this paper
• CD19 chimeric antigen receptor T cell therapy for the treatment of B cell lineage acute lymphoblastic leukemia.

  2015cited by this paper
• Development of 23 individual TaqMan® real-time PCR assays for identifying common foodborne pathogens using a single set of amplification conditions.

  2014cited by this paper
• A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors

  2013cited by this paper
• Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

  2013cited by this paper
• Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions

  2012cited by this paper
• Targeted immunotherapy of cancer with CAR T cells: achievements and challenges

  2012cited by this paper
• Protein L: a novel reagent for the detection of Chimeric Antigen Receptor (CAR) expression by flow cytometry

  2012cited by this paper
• A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.

  2012cited by this paper
• T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

  2011cited by this paper
• Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.

  2010cited by this paper
• Detection and quantitation of bluetongue virus serotypes by a TaqMan probe-based real-time RT-PCR and differentiation from epizootic hemorrhagic disease virus.

  2010cited by this paper
• Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood

  2009cited by this paper
• A gene expression profile for detection of sufficient tumour cells in breast tumour tissue: microarray diagnosis eligibility

  2009cited by this paper
• Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.

  2007cited by this paper
• Fluorescence polarization in homogeneous nucleic acid analysis II: 5'-nuclease assay.

  2001cited by this paper
• Efficient priming of PCR with short oligonucleotides conjugated to a minor groove binder

  1997cited by this paper

• Current Insights of Post-Infusion CAR T Expansion and Persistence for Large B-Cell Lymphoma

  2025cites this paper
• A Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications

  2024cites this paper
• Development of TaqMan-based real-time PCR based on ψ gene for quantitative detection of CAR-T cells.

  2024cites this paper
• Finding your CAR: The road ahead for engineered T-cells.

  2024cites this paper
• Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B-Cell Lymphoma Patients.

  2024cites this paper
• Bioanalytical Methods for Characterization of CAR‐T Cellular Kinetics: Comparison of PCR Assays and Matrices

  2023cites this paper
• Methods to monitor in vivo expansion and efficacy of CAR-T cells in preclinical models.

  2022cites this paper
• Bioanalytical Assay Strategies and Considerations for Measuring Cellular Kinetics

  2022cites this paper
• [Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

  2021cites this paper
• CAR-T cell therapy: practical guide to routine laboratory monitoring.

  2021cites this paper
• Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients

  2021cites this paper
• [Perspectives for the evolution and use of CAR-T cells].

  2021cites this paper
• A Primer on CAR-T Therapy: What Does It Mean for Pathologists?: A Summary Guidance From the College of American Pathologists CAR-T Workgroup.

  2020cites this paper
• Monitoring Allogeneic CAR-T Cells Using Flow Cytometry.

  2020cites this paper
• Feasibility of real-time in vivo 89Zr-DFO-labeled CAR T-cell trafficking using PET imaging

  2020cites this paper
• The Chimeric Antigen Receptor Detection Toolkit

  2020cites this paper
• Detection and Quantification of Chimeric Antigen Receptor Transgene Copy Number by Droplet Digital PCR versus Real-Time PCR.

  2020cites this paper
• Feasibility of real-time in vivo 89Zr-DFO-labeled CAR T-cell trafficking using PET imaging

  2019cites this paper
• World Journal of Clinical Oncology

  year unknowncites this paper